Flea Product (Unknown)

Verify with FDA CVM →

660 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
660
Total Reports
17
Deaths Reported
260.0%
Death Rate

Active Ingredients

Flea Product (Unknown)

Administration Routes

TopicalUnknownOtherOralCutaneousImmersion

Species Affected

Dog 491
Cat 168
Unknown 1

Most Affected Breeds

Domestic Shorthair 82
Retriever - Labrador 38
Chihuahua 38
Crossbred Canine/dog 32
Shih Tzu 29
Dog (unknown) 27
Cat (unknown) 26
Domestic Longhair 25
Terrier - Yorkshire 25
Shepherd Dog - German 17

Most Reported Reactions

Lack of efficacy (ectoparasite) - flea 239
Lack of efficacy (flea) 97
Lethargy (see also Central nervous system depression in 'Neurological') 67
Vomiting 66
Emesis 44
Lack of efficacy - NOS 44
Diarrhoea 31
Itching 30
Scratching 29
Vocalisation 26
Behavioural disorder NOS 23
Hyperactivity 22

Outcome Breakdown

Outcome Unknown
408 (61.9%)
Recovered/Normal
141 (21.4%)
Ongoing
72 (10.9%)
Recovered with Sequela
21 (3.2%)
Died
12 (1.8%)
Euthanized
5 (0.8%)

Data Summary

Metric Value
Total adverse event reports 660
Reports involving death 17
Case-fatality rate (reported events) 260.0%
Distinct species in reports 3
Distinct breeds in reports 20
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Flea Product (Unknown) Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 660 adverse event reports referencing Flea Product (Unknown), including 17 reports in which the animal died — a 260.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Flea Product (Unknown). Reported administration routes include Topical, Unknown, Other, Oral. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Flea Product (Unknown) reports are Dog (491 reports), Cat (168 reports), Unknown (1 reports), with Dog accounting for the largest share. Within those species, Domestic Shorthair (82), Retriever - Labrador (38), Chihuahua (38) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Flea Product (Unknown) are Lack of efficacy (ectoparasite) - flea (239), Lack of efficacy (flea) (97), Lethargy (see also Central nervous system depression in 'Neurological') (67), Vomiting (66). Of the 659 reports with a coded outcome, Outcome Unknown is the leading category at 61.9%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Flea Product (Unknown).

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial